FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953024154> ?p ?o ?g. }

• W2953024154 endingPage "2929" @default.
• W2953024154 startingPage "2915" @default.
• W2953024154 abstract "The efficacy and safety of aspirin for primary prevention of cardiovascular disease (CVD) remain debatable. The purpose of this study was to examine the clinical outcomes with aspirin for primary prevention of CVD after the recent publication of large trials adding >45,000 individuals to the published data. Randomized controlled trials comparing clinical outcomes with aspirin versus control for primary prevention with follow-up duration of ≥1 year were included. Efficacy outcomes included all-cause death, cardiovascular (CV) death, myocardial infarction (MI), stroke, transient ischemic attack (TIA), and major adverse cardiovascular events. Safety outcomes included major bleeding, intracranial bleeding, fatal bleeding, and major gastrointestinal (GI) bleeding. Random effects DerSimonian-Laird risk ratios (RRs) for outcomes were calculated. A total of 15 randomized controlled trials including 165,502 participants (aspirin n = 83,529, control n = 81,973) were available for analysis. Compared with control, aspirin was associated with similar all-cause death (RR: 0.97; 95% confidence interval [CI]: 0.93 to 1.01), CV death (RR: 0.93; 95% CI: 0.86 to 1.00), and non-CV death (RR: 0.98; 95% CI: 0.92 to 1.05), but a lower risk of nonfatal MI (RR: 0.82; 95% CI: 0.72 to 0.94), TIA (RR: 0.79; 95% CI: 0.71 to 0.89), and ischemic stroke (RR: 0.87; 95% CI: 0.79 to 0.95). Aspirin was associated with a higher risk of major bleeding (RR: 1.5; 95% CI: 1.33 to 1.69), intracranial bleeding (RR: 1.32; 95% CI: 1.12 to 1.55), and major GI bleeding (RR: 1.52; 95% CI: 1.34 to 1.73), with similar rates of fatal bleeding (RR: 1.09; 95% CI: 0.78 to 1.55) compared with the control subjects. Total cancer and cancer-related deaths were similar in both groups within the follow-up period of the study. Aspirin for primary prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events." @default.
• W2953024154 created "2019-06-27" @default.
• W2953024154 creator A5004995957 @default.
• W2953024154 creator A5010571732 @default.
• W2953024154 creator A5012614640 @default.
• W2953024154 creator A5017757820 @default.
• W2953024154 creator A5018438729 @default.
• W2953024154 creator A5025991752 @default.
• W2953024154 creator A5043412626 @default.
• W2953024154 creator A5072603443 @default.
• W2953024154 creator A5077000493 @default.
• W2953024154 creator A5083521744 @default.
• W2953024154 creator A5086315099 @default.
• W2953024154 creator A5091184874 @default.
• W2953024154 date "2019-06-01" @default.
• W2953024154 modified "2023-10-11" @default.
• W2953024154 title "Aspirin for Primary Prevention of Cardiovascular Events" @default.
• W2953024154 cites W1810855509 @default.
• W2953024154 cites W1969956137 @default.
• W2953024154 cites W1972566357 @default.
• W2953024154 cites W1986003353 @default.
• W2953024154 cites W2007718786 @default.
• W2953024154 cites W2026458617 @default.
• W2953024154 cites W2034942998 @default.
• W2953024154 cites W2040654890 @default.
• W2953024154 cites W2046481610 @default.
• W2953024154 cites W2048267686 @default.
• W2953024154 cites W2050820265 @default.
• W2953024154 cites W2079115892 @default.
• W2953024154 cites W2087242360 @default.
• W2953024154 cites W2098923148 @default.
• W2953024154 cites W2100012557 @default.
• W2953024154 cites W2100089051 @default.
• W2953024154 cites W2104421238 @default.
• W2953024154 cites W2107328434 @default.
• W2953024154 cites W2111175587 @default.
• W2953024154 cites W2124247204 @default.
• W2953024154 cites W2125435699 @default.
• W2953024154 cites W2127395662 @default.
• W2953024154 cites W2130549133 @default.
• W2953024154 cites W2137408480 @default.
• W2953024154 cites W2138597449 @default.
• W2953024154 cites W2151036184 @default.
• W2953024154 cites W2156538498 @default.
• W2953024154 cites W2157823046 @default.
• W2953024154 cites W2164096839 @default.
• W2953024154 cites W2164822358 @default.
• W2953024154 cites W2180664789 @default.
• W2953024154 cites W2188507800 @default.
• W2953024154 cites W2318931832 @default.
• W2953024154 cites W2331422116 @default.
• W2953024154 cites W2332455909 @default.
• W2953024154 cites W2333990647 @default.
• W2953024154 cites W2346445964 @default.
• W2953024154 cites W2402599050 @default.
• W2953024154 cites W2614578122 @default.
• W2953024154 cites W2806126811 @default.
• W2953024154 cites W2885843995 @default.
• W2953024154 cites W2888108651 @default.
• W2953024154 cites W2889884522 @default.
• W2953024154 cites W2892288854 @default.
• W2953024154 cites W2899755710 @default.
• W2953024154 cites W2904205413 @default.
• W2953024154 cites W2914972362 @default.
• W2953024154 cites W4211201192 @default.
• W2953024154 cites W4245466284 @default.
• W2953024154 cites W60172896 @default.
• W2953024154 doi "https://doi.org/10.1016/j.jacc.2019.03.501" @default.
• W2953024154 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31196447" @default.
• W2953024154 hasPublicationYear "2019" @default.
• W2953024154 type Work @default.
• W2953024154 sameAs 2953024154 @default.
• W2953024154 citedByCount "81" @default.
• W2953024154 countsByYear W29530241542019 @default.
• W2953024154 countsByYear W29530241542020 @default.
• W2953024154 countsByYear W29530241542021 @default.
• W2953024154 countsByYear W29530241542022 @default.
• W2953024154 countsByYear W29530241542023 @default.
• W2953024154 crossrefType "journal-article" @default.
• W2953024154 hasAuthorship W2953024154A5004995957 @default.
• W2953024154 hasAuthorship W2953024154A5010571732 @default.
• W2953024154 hasAuthorship W2953024154A5012614640 @default.
• W2953024154 hasAuthorship W2953024154A5017757820 @default.
• W2953024154 hasAuthorship W2953024154A5018438729 @default.
• W2953024154 hasAuthorship W2953024154A5025991752 @default.
• W2953024154 hasAuthorship W2953024154A5043412626 @default.
• W2953024154 hasAuthorship W2953024154A5072603443 @default.
• W2953024154 hasAuthorship W2953024154A5077000493 @default.
• W2953024154 hasAuthorship W2953024154A5083521744 @default.
• W2953024154 hasAuthorship W2953024154A5086315099 @default.
• W2953024154 hasAuthorship W2953024154A5091184874 @default.
• W2953024154 hasBestOaLocation W29530241541 @default.
• W2953024154 hasConcept C126322002 @default.
• W2953024154 hasConcept C127413603 @default.
• W2953024154 hasConcept C141071460 @default.
• W2953024154 hasConcept C168563851 @default.
• W2953024154 hasConcept C197934379 @default.
• W2953024154 hasConcept C2777628954 @default.

• next